ARX:ASX
Aroa Biosurgery Ltd
A$0.48
arrow_downward
-1.02%(-0.0050) 1D
Nov 20, 4:10:08 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
A$0.50
High
A$0.50
Low
A$0.48
Mkt. cap
167.76M
Avg. vol.
259.42K
Volume
192.34K
P/E ratio
46.19
52-wk high
A$0.78
52-wk low
A$0.46
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
Open
A$0.50
High
A$0.50
Low
A$0.48
Mkt. cap
167.76M
Avg. vol.
259.42K
Volume
192.34K
P/E ratio
46.19
52-wk high
A$0.78
52-wk low
A$0.46
EPS
A$0.01
Shares outstanding
345.90M
No. of employees
261
News stories
From web sources and news partners
The Motley Fool
·
48 minutes ago
The S&P 500 Heads Into Thanksgiving Below Its Peak. Here's How the Holiday Week Has Usually Gone Since 1950.
24/7 Wall St.
·
13 minutes ago
T-Bills Are Beating the Nasdaq, S&P 500 and Dow This Year
Traders Union
·
4 hours ago
Seventeen of the twenty largest S&P 500 drops began below the 200-day moving average, Ryan Detrick notes
cwibc.co.id
·
1 hour ago
S&P 500 Tech Sector Falls 23% Into Bear Market
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd